Table of contents
21 February 2017
Hepatology Highlights
Jean‐François Dufour – 21 February 2017
Sofosbuvir‐velpatasvir‐voxilaprevir with or without ribavirin in direct‐acting antiviral–experienced patients with genotype 1 hepatitis C virus
Eric Lawitz, Fred Poordad, Jennifer Wells, Robert H. Hyland, Yin Yang, Hadas Dvory‐Sobol, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Carmen Landaverde, Julio Gutierrez – 21 February 2017 – The optimal retreatment strategy for hepatitis C virus (HCV) genotype 1–infected patients who fail direct‐acting antiviral (DAA)‐based regimens remains unknown.
Masthead
21 February 2017
Inflammation is independent of steatosis in a murine model of steatohepatitis
Wei Wang, Ming‐Jiang Xu, Yan Cai, Zhou Zhou, Haixia Cao, Partha Mukhopadhyay, Pal Pacher, Shusen Zheng, Frank J. Gonzalez, Bin Gao – 21 February 2017 – Obesity and alcohol consumption synergistically promote steatohepatitis, and neutrophil infiltration is believed to be associated with steatosis. However, the underlying mechanisms remain obscure.
Magnetic resonance elastography for prediction of radiation‐induced liver disease after stereotactic body radiation therapy
Shintaro Ichikawa, Utaroh Motosugi, Mitsuhiko Oguri, Hiroshi Onishi – 20 February 2017
Magnetic resonance elastography for prediction of radiation‐induced liver disease after stereotactic body radiation therapy
Shintaro Ichikawa, Utaroh Motosugi, Mitsuhiko Oguri, Hiroshi Onishi – 20 February 2017
Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma
Behnam Saberi, Alia S. Dadabhai, Christine M. Durand, Benjamin Philosophe, Andrew M. Cameron, Mark S. Sulkowski, Ahmet Gurakar – 17 February 2017
Development of proteinuria and focal segmental glomerulosclerosis during direct‐acting antiviral therapy for hepatitis C virus infection
Jonathan J. Hogan, Mary Ann Lim, Matthew B. Palmer, Roy D. Bloom, Raymond T. Chung, Meghan E. Sise – 17 February 2017
Development of proteinuria and focal segmental glomerulosclerosis during direct‐acting antiviral therapy for hepatitis C virus infection
Jonathan J. Hogan, Mary Ann Lim, Matthew B. Palmer, Roy D. Bloom, Raymond T. Chung, Meghan E. Sise – 17 February 2017